Trial · NCT06680206
Results by group468
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 468
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Rimegepant | Prescription Drug only | 74 | Participants | |
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Triptans | Prescription Drug only | 682 | Participants | |
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Rimegepant | Prescription drug and OTC | 61 | Participants | |
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Triptans | Prescription drug and OTC | 578 | Participants | |
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Rimegepant | OTC only | 0 | Participants | |
| Number of Participants According to Migraine Medication Type (Prescription Drug or Over the Counter [OTC]) | Triptans | OTC only | 0 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Rimegepant | Acute use only | 0 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Triptans | Acute use only | 837 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Rimegepant | Prevention use only | 0 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Triptans | Prevention use only | 0 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Rimegepant | Both Acute and Prevention use | 135 | Participants | |
| Number of Participants According to Migraine Treatment Type (Acute or Prevention) | Triptans | Both Acute and Prevention use | 423 | Participants | |
| Total Number of Acute Migraine Agent Drug Classes Used | Rimegepant | 2.1 | Standard Deviation 1.2 | Drug classes per participant | |
| Total Number of Acute Migraine Agent Drug Classes Used | Triptans | 2.2 | Standard Deviation 1.2 | Drug classes per participant | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Rimegepant | 1 drug class | 51 | Participants | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Triptans | 1 drug class | 431 | Participants | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Rimegepant | 2 or more drug classes | 84 | Participants | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Triptans | 2 or more drug classes | 829 | Participants | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Rimegepant | 3 or more drug classes | 40 | Participants | |
| Number of Participants According to Number of Acute Migraine Agent Drug Classes Used | Triptans | 3 or more drug classes | 406 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06680206/results